Report title: Asia-Pacific Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
from Global Markets Direct - Market Research
87 page report published Sep 28, 2009

Price $2,500.00 available for immediate download
Report Overview
 
Table of Contents
 
Search Inside
 
About Global Markets Direct - Market...

SummaryThis report is an essential source for in-depth information and data relating to Asia Pacific drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Asia Pacific Scope- The report provides information on the drug delivery devices market in the Asia Pacific. - Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.- Total revenues, products sold and end users.- Market shares of all the key competitors such as AstraZeneca International plc, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Novartis AG, and Terumo Corporation. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.- Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data.Reasons to buy- Gain a strong understanding of the drug delivery devices market in Asia Pacific.- Evaluate and compare the attractiveness of the market in the region. - Identify growth segments and opportunities in each industry sector within the region.- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.- Analyze the competitiveness of the market in the region and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the region. - Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

Source: Global Markets Direct
Document ID: GMDME0947ICR
Industry: Medical Devices & Diagnostics
Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat

Sections
TitleStarting PageNumber of Pages
1 Table of Contents29
1.1 List of Tables72
1.2 List of Figures92
2 Introduction111
2.1 What Is This Report About?111
3 Definitions of Markets Covered in This Report121
3.1 Drug delivery devices121
3.2 Needle-free Injections121
3.3 Inhalation Systems121
3.4 Infusion Systems121
4 Drug Delivery Devices in Asia-Pacific138
4.1 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($ mn), 2000-2015134
4.2 Drug Delivery Devices, Asia-Pacific, Category Volume (Units), 2000-2015173
4.3 Drug Delivery Devices, Asia-Pacific, Company share (2007-2008)201
5 Drug Delivery Devices In Japan2111
5.1 Drug Delivery Devices, Japan, Overall Revenue ($ mn), 2000-2015213
5.2 Drug Delivery Devices, Japan, Category Volume (Units), 2000-2015243
5.3 Drug Delivery Devices, Japan, Distribution Share (2007-2008)271
5.3.1 Infusion Systems Distribution Share (2007-2008) 271
5.3.2 Inhalation Systems Distribution Share (2007-2008) 271
5.3.3 Needle Free Injections Distribution Share (2007-2008) 281
5.4 Drug Delivery Devices, Japan, Company Share (2007-2008)291
5.4.1 Drug Delivery Devices, Japan, Company Share (2007-2008)291
5.4.2 Infusion Systems, Japan, Company Share (2007-2008)301
5.4.3 Inhalation Systems, Japan, Company Share (2007-2008)311
6 Drug Delivery Devices In China3210
6.1 Drug Delivery Devices, China, Overall Revenue ($ mn), 2000-2015323
6.2 Drug Delivery Devices, China, Category Volume (Units), 2000-2015353
6.3 Drug Delivery Devices, China, Distribution Share (2007-2008) 381
6.3.1 Infusion Systems Distribution Share (2007-2008) 381
6.3.2 Inhalation Systems Distribution Share (2007-2008) 381
6.4 Drug Delivery Devices, China, Company Share (2007-2008)391
6.4.1 Drug Delivery Devices, China, Company Share (2007-2008)391
6.4.2 Infusion Systems, China, Company Share (2007-2008)401
6.4.3 Inhalation Systems, China, Company Share (2007-2008)411
7 Drug Delivery Devices In Australia4210
7.1 Drug Delivery Devices, Australia, Overall Revenue ($ mn), 2000-2015423
7.2 Drug Delivery Devices, Australia, Category Volume (Units), 2000-2015453
7.3 Drug Delivery Devices, Australia, Distribution Share (2007-2008)481
7.3.1 Infusion Systems Distribution Share (2007-2008) 481
7.3.2 Inhalation Systems Distribution Share (2007-2008) 481
7.4 Drug Delivery Devices, Australia, Company Share (2007-2008)491
7.4.1 Drug Delivery Devices, Australia, Company Share (2007-2008)491
7.4.2 Infusion Systems, Australia, Company Share (2007-2008)501
7.4.3 Inhalation Systems, Australia, Company Share (2007-2008)511
8 Drug Delivery Devices In India5211
8.1 Drug Delivery Devices, India, Overall Revenue ($ mn), 2000-2015523
8.2 Drug Delivery Devices, India, Category Volume (Units), 2000-2015553
8.3 Drug Delivery Devices, India, Distribution Share (2007-2008) 581
8.3.1 Infusion Systems Distribution Share (2007-2008) 581
8.3.2 Inhalation Systems Distribution Share (2007-2008) 581
8.4 Drug Delivery Devices, India, Company Share (2007-2008)591
8.4.1 Drug Delivery Devices, India, Company Share (2007-2008)591
8.4.2 Infusion Systems, India, Company Share (2007-2008)602
8.4.3 Inhalation Systems, India, Company Share (2007-2008)621
9 Overview of Key Companies in Asia-Pacific Drug Delivery Devices Market6315
9.1 AstraZeneca PLC 631
9.1.1 Company Overview631
9.2 Boehringer Ingelheim GmbH 631
9.2.1 Company Overview631
9.3 Baxter International Inc. 641
9.3.1 Company Overview641
9.4.1 Company Overview641
9.5 Terumo Corporation651
9.5.1 Company Overview651
9.5.2 Terumo Corporation Pipeline Products651
9.5.2.1 Terumo Corporation Pipeline Products By Equipment Type651
9.5.2.2 Terumo Corporation Pipeline Products By Development Stage651
9.5.2.3 Terumo Corporation Pipeline Products By Therapy Area661
9.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials661
9.5.2.5 Terumo Corporation Pipeline Products By News Summary671
9.6 Cardinal Health, Inc. 681
9.6.1 Company Overview681
9.7 NIPRO CORPORATION681
9.7.1 Company Overview681
9.8 GlaxoSmithKline plc 691
9.8.1 Company Overview691
9.9 B. Braun Melsungen AG 701
9.9.1 Company Overview701
9.10 Smiths Medical 701
9.10.1 Company Overview701
9.11 Fresenius Kabi AG711
9.11.1 Company Overview711
9.12 JMS CO., LTD.711
9.12.1 Company Overview711
9.13 Bioject Medical Technologies Inc.721
9.13.1 Company Overview721
9.13.2 Bioject Medical Technologies Inc. Pipeline Products721
9.13.2.1 Bioject Medical Technologies Inc. Pipeline Products By Equipment Type721
9.13.2.2 Bioject Medical Technologies Inc. Pipeline Products By Development Stage721
9.13.2.3 Bioject Medical Technologies Inc. Pipeline Products By Therapy Area731
9.13.2.4 Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials731
9.13.2.5 Bioject Medical Technologies Inc. Pipeline Products By News Summary731
9.14 Consort Medical plc 741
9.14.1 Company Overview741
9.14.2 Consort Medical plc Pipeline Products741
9.14.2.1 Bespak plc Pipeline Products By Equipment Type741
9.14.2.2 Bespak plc Pipeline Products By Development Stage741
9.14.2.3 Bespak plc Pipeline Products By Therapy Area751
9.15 Hospira, Inc. 761
9.16 Daiken Medical Co., Ltd.771
9.16.1 Company Overview771
9.17.1 Company Overview771
9.18 Plenum Technologies Private Limited771
9.18.1 Company Overview771
10 Financial Deals Landscape784
11 Recent Developments821
11.1 Strategy and Business Planning821
11.1.1 May 18, 2009: 3M CUNO Establishes Filter Validation Lab821
11.1.2 May 17, 2009: Piramal Life Sciences Plans INR 2 Billion Investment In R&D821
12 Appendix835
12.1 Global Markets Direct Research Methodology831
12.2 Secondary Research841
12.3 Primary Research841
12.4 Models851
12.5 Forecasts851
12.6 Expert Panel Validation851
12.7 Currency Conversion861
12.8 Contact Us871
12.9 Disclaimer871

Enter the keyword(s) which you would like to search for within this document and click "Search"  


Price: $2,500.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.